Literature DB >> 28581467

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

K Fleischhauer1, K W Ahn2, H L Wang2, L Zito3, P Crivello1, C Müller4, M Verneris5, B E Shaw2, J Pidala6, M Oudshorn7, S J Lee2,8, S R Spellman9.   

Abstract

In 8/8 HLA-matched unrelated donor (UD) hematopoietic cell transplants (HCT), HLA-DPB1 mismatches between alleles from different T-cell epitope (TCE) groups (non-permissive mismatches) are associated with significantly higher risks of mortality compared with those between alleles from the same TCE group (permissive mismatches); however, the relevance of mismatch directionality, that is (host vs graft (uni-directional HvG), graft vs host (uni-directional GvH) or both (bi-directional) in the non-permissive setting is unknown. We show here significantly higher in vitro relative responses (RR) to bi-directional mismatches compared with uni-directional HvG or GvH mismatches in a total of 420 one-way mixed lymphocyte reactions between 10/10 matched pairs (RR 27.5 vs 7.5 vs 15.5, respectively, P<0.001). However, in 3281 8/8 matched UD HCT for leukemia or myelodysplastic syndrome, the hazards of transplant-related mortality (TRM) were similar for uni-directional HvG or GvH mismatches and bi-directional mismatches (hazard ratio (HR) 1.32, P=0.001 vs HR 1.28, P=0.005 and HR 1.34, P=0.046), compared with permissive mismatches. Similar results were observed for overall survival. No statistical differences between the uni- and the bi-directional non-permissive groups were detected in pairwise comparisons for any of the outcomes tested. We conclude that consideration of directionality does not improve risk stratification by non-permissive HLA-DPB1 TCE mismatches in UD searches.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28581467      PMCID: PMC5968827          DOI: 10.1038/bmt.2017.96

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  32 in total

1.  Immunogenetics of HLA-DP--A New View of Permissible Mismatches.

Authors:  Katharina Fleischhauer
Journal:  N Engl J Med       Date:  2015-08-13       Impact factor: 91.245

2.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

3.  A proposed algorithm predictive for cytotoxic T cell alloreactivity.

Authors:  Monique M Jöris; Jon J van Rood; Dave L Roelen; Machteld Oudshoorn; Frans H J Claas
Journal:  J Immunol       Date:  2012-01-18       Impact factor: 5.422

4.  Typing for MLC (LD). I. Lymphocytes from cousin-marriage offspring as typing cells.

Authors:  J G van den Tweel; A B van Oud Alblas; J J Keuning; E Goulmy; A Termijtelen; M L Bach; J J van Rood
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

6.  Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.

Authors:  Junya Kanda; Tatsuo Ichinohe; Shigeo Fuji; Yoshinobu Maeda; Kazuteru Ohashi; Takahiro Fukuda; Koichi Miyamura; Koji Iwato; Tetsuya Eto; Hirohisa Nakamae; Naoki Kobayashi; Takehiko Mori; Shin-Ichiro Mori; Yasuo Morishima; Yoshiko Atsuta; Yoshinobu Kanda
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-18       Impact factor: 5.742

Review 7.  Optimal HLA matching in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  Curr Opin Immunol       Date:  2008-08-08       Impact factor: 7.486

8.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

9.  Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.

Authors:  K Fleischhauer; M A Fernandez-Viña; T Wang; M Haagenson; M Battiwalla; L A Baxter-Lowe; F Ciceri; J Dehn; J Gajewski; G A Hale; M B A Heemskerk; S R Marino; P L McCarthy; D Miklos; M Oudshoorn; M S Pollack; V Reddy; D Senitzer; B E Shaw; E K Waller; S J Lee; S R Spellman
Journal:  Bone Marrow Transplant       Date:  2014-06-23       Impact factor: 5.483

10.  A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.

Authors:  W Bochtler; L Gragert; Z I Patel; J Robinson; D Steiner; J A Hofmann; J Pingel; A Baouz; A Melis; J Schneider; H-P Eberhard; M Oudshoorn; S G E Marsh; M Maiers; C R Müller
Journal:  HLA       Date:  2016-05-24       Impact factor: 4.513

View more
  5 in total

1.  Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.

Authors:  Jun Zou; Stefan O Ciurea; Piyanuch Kongtim; Min Yi; Yudith Carmazzi; Gabriela Rondon; Samer Srour; David Partlow; Richard E Champlin; Kai Cao
Journal:  Blood Adv       Date:  2020-08-11

2.  In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.

Authors:  Esteban Arrieta-Bolaños; Pietro Crivello; Bronwen E Shaw; Kwang Woo Ahn; Hai-Lin Wang; Michael R Verneris; Katharine C Hsu; Joseph Pidala; Stephanie J Lee; Katharina Fleischhauer; Stephen R Spellman
Journal:  Blood Adv       Date:  2018-07-24

Review 3.  Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.

Authors:  Jason Dehn; Stephen Spellman; Carolyn K Hurley; Bronwen E Shaw; Juliet N Barker; Linda J Burns; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Robert Hartzman; Martin Maiers; Susana R Marino; Carlheinz Mueller; Miguel-Angel Perales; Raja Rajalingam; Joseph Pidala
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

4.  The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.

Authors:  Daphne Mytilineos; Chrysanthi Tsamadou; Christine Neuchel; Uwe Platzbecker; Donald Bunjes; Natalie Schub; Eva Wagner-Drouet; Gerald Wulf; Nicolaus Kröger; Niels Murawski; Hermann Einsele; Kerstin Schaefer-Eckart; Sebastian Freitag; Jochen Casper; Martin Kaufmann; Mareike Dürholt; Bernd Hertenstein; Stefan Klein; Mark Ringhoffer; Carlheinz R Mueller; Sandra Frank; Hubert Schrezenmeier; Daniel Fuerst; Joannis Mytilineos
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

5.  Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.

Authors:  Jun Zou; Piyanuch Kongtim; Betül Oran; Vasilis Kosmoliaptsis; Yudith Carmazzi; Junsheng Ma; Liang Li; Gabriela Rondon; Samer Srour; Hannah C Copley; David Partlow; Stefan O Ciurea; Uri Greenbaum; Qing Ma; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.